Month: January 2009

  •     By Kevin E. Noonan — The Federal Circuit will hear oral argument on Thursday for In re Kubin, a case having great significance for biotechnology patenting.  At issue is the question of whether the existence in the prior art of a purified protein, combined with "routine" cloning methods, renders obvious a claim to a…

  •     By Kevin E. Noonan — A change of administration always gives stakeholders a chance to make their policy views known, in an effort to influence the new people and policies taking power in Washington.  This is particularly true in this season of (welcome) change, and even more important for U.S. patent law, in view…

  •     By Donald Zuhn — Yesterday, we counted down stories #9 to #6 of the top stories covered at Patent Docs in 2008 (see "Top Stories of 2008: #9 to #6"), and on New Year's Day, we listed stories #13 to #10 (see "Top Stories of 2008: #13 to #10").  Today, we conclude our second…

  •     By Donald Zuhn — On New Year's Day, we counted down the first four of the top thirteen stories covered on Patent Docs in 2008 (see "Top Stories of 2008: #13 to #10").  Today, we count down stories #9 to #6, and tomorrow, we will count down last year's top five stories.  In case…

  •     By Sherri Oslick — About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Monsanto Co. et al. v. Pilman4:08-cv-02020; filed December 30, 2008 in the Eastern District of Missouri Infringement of U.S. Patent Nos. 5,352,605…

  • January 12-13, 2009 – Pharmaceutical and Biotech Patent Opinion Writing*** (American Conference Institute) – San Diego, CA January 20-21, 2009 – Bio/Pharmaceutical Summit on Legal and Regulatory Product Lifecycle Strategies*** (Center for Business Intelligence) – Baltimore, MD January 26-27, 2009 – Structuring and Negotiating Pharma & Biotech Collaborative Agreements (C5) – London, England January 27-28,…

  •     By Donald Zuhn — In November, we noted that the nation's largest mail order pharmacy, Franklin Lakes, NJ-based Medco Health Solutions, Inc., had announced that consumers could expect to see the establishment of a follow-on biologics regulatory pathway in the United States by 2011 (see "Medco Predicts Follow-on Biologics Regulatory Pathway by 2011").  Medco…

  •     By Donald Zuhn — Reflecting upon the events of the past twelve months, Patent Docs presents its second annual list of top biotech/pharma stories.  For 2008, we identified a baker's dozen of top stories covered on Patent Docs.  Today we will count down stories #13 to #10.  On Sunday, we will present stories #9…